Erratum: CCL2 enhances pluripotency of human induced pluripotent stem cells by activating hypoxia related genes (Scientific Reports (2014) 4 (5228) DOI: 10.1038/srep05228);CCL2 enhances pluripotency of human induced pluripotent stem cells by activating hypoxia related genes

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Hasegawa, Yuki ^a,b   Tang, Dave ^a,b   Takahashi, Naoko ^a,b   Hayashizaki, Yoshihide ^a,b   Forrest, Alistair R R ^a,b   Suzuki, Harukazu ^a,b  

^a RIKEN YOKOHAMA INSTITUTE   (Japan)

^b RIKEN   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKENE; DPPA3 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR 2; HOMEODOMAIN PROTEIN; J 104129; JANUS KINASE; JANUS KINASE 1; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 4; MONOCYTE CHEMOTACTIC PROTEIN 1; NANOG PROTEIN, HUMAN; PIPERIDINE DERIVATIVE; PROTEIN; STAGE SPECIFIC EMBRYO ANTIGEN; STAGE-SPECIFIC EMBRYONIC ANTIGEN-4; STAT3 PROTEIN; ZFP42 PROTEIN, HUMAN;

CELL CULTURE; CELL DIFFERENTIATION; CELL HYPOXIA; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; METABOLISM; PHOSPHORYLATION; PLURIPOTENT STEM CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ALKENES; CELL DIFFERENTIATION; CELL HYPOXIA; CELLS, CULTURED; CHEMOKINE CCL2; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INDUCED PLURIPOTENT STEM CELLS; JANUS KINASE 1; JANUS KINASES; KRUPPEL-LIKE TRANSCRIPTION FACTORS; PHOSPHORYLATION; PIPERIDINES; PLURIPOTENT STEM CELLS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAGE-SPECIFIC EMBRYONIC ANTIGENS; STAT3 TRANSCRIPTION FACTOR;

EID: 84903131662     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06385     Document Type: Erratum

References (43)

1. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676, doi:10.1016/j.cell.2006.07.024 (2006). (Pubitemid 44233629)
2. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872, doi:10.1016/j.cell.2007.11. 019 (2007). (Pubitemid 350138099)
3. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920, doi:10.1126/science.1151526 (2007).
4. Nichols, J. & Smith, A. Naive and primed pluripotent states. Cell Stem Cell 4, 487-492, doi:10.1016/j.stem.2009.05.015 (2009).
5. Chin, M. H. et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5, 111-123, doi:10.1016/j.stem.2009.06.008 (2009).
6. Fan, G. & Tran, J. X chromosome inactivation in human and mouse pluripotent stem cells. Hum Genet 130, 217-222, doi:10.1007/s00439-011-1038-1 (2011).
7. Ying, Q. L. et al. The ground state of embryonic stem cell self-renewal. Nature 453, 519-523, doi:10.1038/nature06968 (2008). (Pubitemid 351733324)
8. Silva, J. & Smith, A. Capturing pluripotency. Cell 132, 532-536, doi:10.1016/j.cell.2008.02.006 (2008). (Pubitemid 351253697)
9. Tesar, P. J. et al. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448, 196-199, doi:10.1038/nature05972 (2007). (Pubitemid 47067378)
10. Hanna, J. et al. Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci U S A 107, 9222-9227, doi:10.1073/pnas.1004584107 (2010).
11. Ojala, M. et al. Culture conditions affect cardiac differentiation potential of human pluripotent stem cells. PLoS One 7, e48659, doi:10.1371/journal.pone.0048659 (2012).
12. Silva, S. S., Rowntree, R. K., Mekhoubad, S. & Lee, J. T. X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells. Proc Natl Acad Sci U S A 105, 4820-4825, doi:10.1073/pnas.0712136105 (2008). (Pubitemid 351753830)
13. Tomoda, K. et al. Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells. Cell Stem Cell 11, 91-99, doi:10.1016/j.stem.2012.05.019 (2012).
14. Yoshida, Y., Takahashi, K., Okita, K., Ichisaka, T. & Yamanaka, S. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 5, 237-241, doi:10.1016/j.stem.2009.08.001 (2009).
15. Forristal, C. E., Wright, K. L., Hanley, N. A., Oreffo, R. O. & Houghton, F. D. Hypoxia inducible factors regulate pluripotency and proliferation in human embryonic stem cells cultured at reduced oxygen tensions. Reproduction 139, 85-97, doi:10.1530/REP-09-0300 (2010).
16. Mathieu, J. et al. Hypoxia induces re-entry of committed cells into pluripotency. Stem Cells 31, 1737-1748, doi:10.1002/stem.1446 (2013).
17. Lengner, C. J. et al. Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell 141, 872-883, doi:10.1016/j.cell.2010.04.010 (2010).
18. Martin, M. J., Muotri, A., Gage, F. & Varki, A. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 11, 228-232, doi:10.1038/nm1181 (2005). (Pubitemid 40321360)
19. Vuoristo, S. et al. Laminin isoforms in human embryonic stem cells: synthesis, receptor usage and growth support. J Cell Mol Med 13, 2622-2633, doi:10.1111/j.1582-4934.2008.00643.x (2009).
20. Hasegawa, Y. et al. CC chemokine ligand 2 and leukemia inhibitory factor cooperatively promote pluripotency in mouse induced pluripotent cells. Stem Cells 29, 1196-1205, doi:10.1002/stem.673 (2011).
21. Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998). (Pubitemid 28516247)
22. James, D., Levine, A. J., Besser, D. & Hemmati-Brivanlou, A. TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132, 1273-1282, doi:10.1242/dev. 01706 (2005). (Pubitemid 40528787)
23. Yang, J. et al. Stat3 activation is limiting for reprogramming to ground state pluripotency. Cell Stem Cell 7, 319-328, doi:10.1016/j.stem.2010.06.022 (2010).
24. Shiraki, T. et al. Cap analysis gene expression for high-throughput analysis of transcriptional starting point and identification of promoter usage. Proc Natl Acad Sci U S A 100, 15776-15781, doi:10.1073/pnas.2136655100 (2003). (Pubitemid 38021066)
25. Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139-140, doi:10.1093/bioinformatics/btp616 (2010).
26. Mazure, N. M. et al. Repression of alpha-fetoprotein gene expression under hypoxic conditions in human hepatoma cells: characterization of a negative hypoxia response element that mediates opposite effects of hypoxia inducible factor-1 and c-Myc. Cancer Res 62, 1158-1165 (2002). (Pubitemid 34160303)
27. Stowe, A. M. et al. CCL2 upregulation triggers hypoxic preconditioning-induced protection from stroke. J Neuroinflammation 9, 33, doi:10.1186/1742-2094-9-33 (2012).
28. Liu, T. et al. Regulation of S100A4 expression via the JAK2-STAT3 pathway in rhomboid-phenotype pulmonary arterial smooth muscle cells exposure to hypoxia. Int J Biochem Cell Biol 44, 1337-1345, doi:10.1016/j.biocel.2012.04.017 (2012).
29. Maruyama, K. & Sugano, S. Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. Gene 138, 171-174 (1994). (Pubitemid 24087571)
30. Tsuchihara, K. et al. Massive transcriptional start site analysis of human genes in hypoxia cells. Nucleic Acids Res 37, 2249-2263, doi:10.1093/nar/gkp066 (2009).
31. van Oosten, A. L., Costa, Y., Smith, A. & Silva, J. C. JAK/STAT3 signalling is sufficient and dominant over antagonistic cues for the establishment of naive pluripotency. Nat Commun 3, 817, doi:10.1038/ncomms1822 (2012).
32. Wang, Q. et al. A novel xeno-free and feeder-cell-free system for human pluripotent stem cell culture. Protein Cell 3, 51-59, doi:10.1007/s13238-012- 2002-0 (2012).
33. Xu, R. H. et al. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods 2, 185-190, doi:10.1038/nmeth744 (2005). (Pubitemid 41122125)
34. Mori, H. et al. Immobilization of bioactive fibroblast growth factor-2 into cubic proteinous microcrystals (Bombyx mori cypovirus polyhedra) that are insoluble in a physiological cellular environment. J Biol Chem 282, 17289-17296, doi:10.1074/jbc.M608106200 (2007). (Pubitemid 47093237)
35. Nagamatsu, G. et al. Optimal ratio of transcription factors for somatic cell reprogramming. J Biol Chem 287, 36273-36282, doi:10.1074/jbc.M112.380683 (2012).
36. Dunwoodie, S. L. The role of hypoxia in development of the Mammalian embryo. Dev Cell 17, 755-773, doi:10.1016/j.devcel.2009.11.008 (2009).
37. Matsumoto, K. et al. Effects of hypoxia on cholesterol metabolism in human monocyte-derived macrophages. Life Sci 67, 2083-2091 (2000).
38. Mojsilovic-Petrovic, J. et al. Hypoxia-inducible factor-1 (HIF-1) is involved in the regulation of hypoxia-stimulated expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) and MCP-5 (Ccl12) inastrocytes. J Neuroinflammation 4, 12, doi:10.1186/1742-2094-4-12 (2007). (Pubitemid 46831055)
39. Mohyeldin, A., Garzon-Muvdi, T. & Quinones-Hinojosa, A. Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell 7, 150-161, doi:10.1016/j.stem.2010.07.007 (2010).
40. Chen, H. F. et al. Hypoxic culture maintains self-renewal and enhances embryoid body formationofhuman embryonic stem cells. Tissue Eng Part A 16, 2901-2913, doi:10.1089/ten.tea.2009.0722 (2010).
41. Thomsen, R., Solvsten, C. A., Linnet, T. E., Blechingberg, J. & Nielsen, A. L. Analysis of qPCR data by converting exponentially related Ct values into linearly related X0 values. J Bioinform Comput Biol 8, 885-900 (2010).
42. Kanamori-Katayama, M. et al. Unamplified cap analysis of gene expression on a single-molecule sequencer. Genome Res 21, 1150-1159, doi:10.1101/gr.115469. 110 (2011).
43. Supek, F., Bosnjak, M., Skunca, N. & Smuc, T. REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS One 6, e21800, doi:10.1371/journal.pone.0021800 (2011).